Skip to main content

Advertisement

Log in

Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival

  • REVIEW
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Chronic lymphocytic leukemia is a malignant disease characterized by clonal expansion of relatively mature B-lymphocytes with a high percentage of cells arrested in the nonproliferative G0/G1 cell cycle phase. Possibly reflecting the clinical heterogeneity observed in patients, various signaling pathways may become affected during the initiation and course of this disease. This review discusses frequent alterations concerning proliferative, differentiation-inducing, and apoptotic pathways elucidated in the recent years that have improved our understanding of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 2 February 1998 / Accepted: 8 July 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meinhardt, G., Wendtner Clemens-M., . & Hallek, M. Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J Mol Med 77, 282–293 (1999). https://doi.org/10.1007/s001090050351

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001090050351

Navigation